Yasushi Nakazawa
Jikei University School of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yasushi Nakazawa.
The American Journal of the Medical Sciences | 2015
Fumiya Sato; Yumiko Hosaka; Tokio Hoshina; Kumi Tamura; Kazuhiko Nakaharai; Tetsuro Kato; Yasushi Nakazawa; Masaki Yoshida; Seiji Hori
Background:Metastatic infections such as infective endocarditis and psoas abscess are serious complications of Staphylococcus aureus bacteremia because failure to identify these infections may result in bacteremia relapse or poor prognosis. In the present study, we determined the predictive factors for metastatic infection due to methicillin-sensitive S. aureus bacteremia. Methods:A retrospective cohort study was conducted among patients with methicillin-sensitive S. aureus bacteremia at the Jikei University Hospital between January 2008 and December 2012. Factors analyzed included the underlying disease, initial antimicrobial treatment and primary site of infection. Results:During the 5-year study period, 73 patients met the inclusion criteria and were assessed. The most common primary site of bacteremia was catheter-related bloodstream infection (25/73 [34.2%]). Metastatic infection occurred in 14 of 73 patients (19.2%) (infective endocarditis [3], septic pulmonary abscess [3], spondylitis [4], psoas abscess [4], epidural abscess [3] and septic arthritis [1]). Six patients had multiple metastatic infections. Multivariate analysis revealed that the predictive factors associated with the development of metastatic infection were a delay in appropriate antimicrobial treatment of >48 hours, persistent fever for >72 hours after starting antibiotic treatment and lowest C-reactive protein levels of >3 mg/dL during 2 weeks after the onset of bacteremia. Conclusions:This study demonstrated that additional diagnostic tests should be conducted to identify metastatic infection, particularly in patients with delayed antimicrobial treatment, persistent fever and persistently high C-reactive protein levels.
Clinics | 2016
Fumiya Sato; Tetsuro Kato; Yumiko Hosaka; Akihiro Shimizu; Shinji Kawano; Tokio Hoshina; Kazuhiko Nakaharai; Yasushi Nakazawa; Koji Yoshikawa; Masaki Yoshida; Seiji Hori
OBJECTIVES: This study was conducted to clarify the rate of late diagnosis of HIV infection and to identify relationships between the reasons for HIV testing and a late diagnosis. METHODS: This retrospective cohort study was conducted among HIV-positive patients at the Jikei University Hospital between 2001 and 2014. Patient characteristics from medical records, including age, sex, sexuality, the reason for HIV testing and the number of CD4-positive lymphocytes at HIV diagnosis, were assessed. RESULTS: A total of 459 patients (men, n=437; 95.2%) were included in this study and the median age at HIV diagnosis was 36 years (range, 18–71 years). Late (CD4 cell count <350/mm3) and very late (CD4 cell count <200/mm3) diagnoses were observed in 61.4% (282/459) and 36.6% (168/459) of patients, respectively. The most common reason for HIV diagnosis was voluntary testing (38.6%, 177/459 patients), followed by AIDS-defining illness (18.3%, 84/459 patients). Multivariate analysis revealed a significant association of voluntary HIV testing with non-late and non-very-late diagnoses and there was a high proportion of AIDS-defining illness in the late and very late diagnosis groups compared with other groups. Men who have sex with men was a relative factor for non-late diagnosis, whereas nonspecific abnormal blood test results, such as hypergammaglobulinemia and thrombocytopenia, were risk factors for very late diagnosis. CONCLUSIONS: Voluntary HIV testing should be encouraged and physicians should screen all patients who have symptoms or signs and particularly hypergammaglobulinemia and thrombocytopenia, that may nonspecifically indicate HIV infection.
Journal of Infection and Chemotherapy | 2013
Yasushi Nakazawa; Ryoko; Taku Tamura; Tokio Hoshina; Kumiko Tamura; Shinji Kawano; Tetsuro Kato; Fumiya Sato; Masaki Yoshida; Seiji Hori; Masamitsu Sanui; Yoshikazu Ishii; Kazuhiro Tateda
Drugs | 1995
Kohya Shiba; Mitsuo Sakamoto; Yasushi Nakazawa; Osamu Sakai
Internal Medicine | 2012
Akio Chiba; Shinji Kawano; Tetsuro Kato; Fumiya Sato; Yukio Maruyama; Yasushi Nakazawa; Koji Yoshikawa; Masaki Yoshida; Seiji Hori
Internal Medicine | 2008
Tetsuro Kato; Fumiya Sato; Mitsuo Sakamoto; Yasushi Nakazawa; Masaki Yoshida; Shoichi Onodera; Masato Kohda; Koma Matsuo; Takaoki Ishiji; Hideyuki Takahashi; Haruo Watanabe
The Journal of the Japanese Association for Infectious Diseases | 2014
Tokio Hoshina; Kumi Tamura; Shinji Kawano; Tetsurou Kato; Fumiya Sato; Yasushi Nakazawa; Kouji Yosikawa; Masaki Yoshida; Masahiro Kumagai; Seiji Hori
The Journal of the Japanese Association for Infectious Diseases | 1993
Masaki Yoshida; Kouji Yoshikawa; Hiromi Maezawa; Nahoko Shindou; Mitsuo Sakamoto; Yasushi Nakazawa; Kohya Shiba; Atsushi Saito; Osamu Sakai
The Journal of the Japanese Association for Infectious Diseases | 1998
Hiromi Maezawa; Mitsuo Sakamoto; Yasushi Nakazawa; Nahoko Shindo; Kohji Yoshikawa; Masaki Yoshida; Kohya Shiba
Internal Medicine | 2012
Masaki Yoshida; Tokio Hoshina; Kumi Tamura; Shinji Kawano; Tetsuro Kato; Fumiya Sato; Yasushi Nakazawa; Koji Yoshikawa; Shoichi Onodera; Seiji Hori